N-[6-(1-HYDROXY-1-METHYL-ETHYL)-2-(2-METHYLSULFONYLETHYL)INDAZOL-5-YL]-6-(TRIFLUOROMETHYL)PYRIDINE-2-CARBOXAMIDE, 95%, 100mg

Centrifuge tubes conical, without rim, 50 ml, Non-sterile, 300 Piece(s)

tert-Butyl 1,4-diazepane-1-carboxylate, 98.0%, 10g

N-Carbobenzoxy-1,6-diaminohexane Hydrochloride>98.0%(HPLC)(N)5g

METHYL 6-FLUORO-2-METHYL-3-NITROBENZOATE, 95.0%, 100mg

TERT-BUTYL 1-OXO-8-AZASPIRO[4.5]DEC-2-ENE-8-CARBOXYLATE, 95.0%, 250mg

Ethyl 2-((3-bromophenyl)amino)acetate, 95.0%, 250mg

(R)-2-Phenylpropan-1-amine hydrochloride, 97%, 25g

(S)-4-Benzyl-2-(thiophen-2-yl)-4,5-dihydrooxazole, 97%, 100mg

Phenylacetylenecarboxylic acid, min. 98%, for synthesis, 5 g, plastic packaging.

(4-Phenoxyphenyl)methanol, 95.0%, 25g

VGX-1027, 95.0%, 1g

(3S)-tert-Butyl 4-(6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)-2-oxo-1,2-dihydropyrido[2,3-d]pyrimidin-4-yl)-3-methylpiperazine-1-carboxylate, 98%, 1g